Adam Scott Levy, Chief Business Officer at MIRAGEN THERAPEUTICS, INC. (MGEN), bought 200 shares at $7.55 ($2K) on 2017-06-22, disclosed to the SEC on 2017-06-23.
Open-market purchase of $2k MGEN by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| MLYS | SELL | 2025-10-15 | $904K | — | Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |